Jupiter Life Line Hospital has released its Q3 consolidated financial results, presenting a mixed performance with revenue growth, EBITDA expansion, but accompanied by a decline in net profitability. The healthcare services provider's latest quarterly results demonstrate the complex dynamics facing the healthcare sector.

Financial Performance Overview

The company's Q3 consolidated results show contrasting trends across key financial metrics. While the top-line performance remained robust with significant revenue growth and EBITDA expansion, the bottom-line results reflected margin pressures during the quarter.

EBITDA Performance Shows Operational Strength

Jupiter Life Line Hospital demonstrated solid operational performance with EBITDA reaching ₹835 million in Q3, compared to ₹763 million in the same quarter of the previous year. This represents a year-on-year growth of 9.4%, indicating the company's ability to generate strong earnings before interest, taxes, depreciation, and amortization.

The EBITDA margin stood at 22.85% versus 22.93% in the previous year, showing a marginal decline of 8 basis points. Despite this slight compression, the margin remains robust, reflecting the company's operational efficiency in the healthcare services sector.

Revenue Growth Momentum

Jupiter Life Line Hospital demonstrated solid revenue expansion during Q3, with consolidated revenue reaching ₹3.65 billion compared to ₹3.30 billion in the same quarter of the previous year. This represents a year-on-year growth of 10.6%, indicating the company's ability to expand its business operations and maintain patient volume growth.

The revenue increase suggests sustained demand for the hospital's healthcare services and potentially reflects expansion in service offerings or patient capacity utilization during the quarter.

Profitability Challenges

Despite the positive revenue trajectory and EBITDA growth, Jupiter Life Line Hospital faced profitability headwinds during Q3. The consolidated net profit declined to ₹426 million from ₹521 million in the corresponding quarter last year, representing an 18.2% year-on-year decrease.

The divergence between EBITDA growth and profit decline indicates that factors below the EBITDA line, such as depreciation, interest expenses, or tax provisions, may have impacted the final profitability during the quarter.

Key Financial Highlights

The Q3 results present several notable aspects of Jupiter Life Line Hospital's financial performance:

• Revenue resilience: 10.6% year-on-year growth demonstrates business expansion capabilities
• EBITDA strength: 9.4% growth with healthy margin of 22.85% shows operational efficiency
• Profit pressure: 18.2% decline in net profit highlights challenges in non-operational expenses
• Scale operations: Consolidated revenue of ₹3.65 billion reflects significant business scale

The mixed quarterly performance reflects the operational complexities in the healthcare services industry, where revenue growth and EBITDA expansion demonstrate core business strength, while profitability optimization requires careful management of all cost components.

Jupiter Life Line Hospital Limited has announced its earnings conference call to discuss the operational and financial performance for Q3 & 9M FY26. The call is scheduled for February 02, 2026 at 10:00 AM IST and will provide insights into the company's quarterly and nine-month performance.

Conference Call Details

The earnings call will be represented by Dr. Ankit Thakker, Joint Managing Director and CEO, along with the senior management team. The company has issued formal notification to both National Stock Exchange of India Limited and BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Access Information

Investors and analysts interested in participating in the earnings call are required to pre-register through the company's designated registration link. The company has provided multiple access numbers to accommodate participants from different regions.

Regulatory Compliance

The company has fulfilled its regulatory obligations by notifying the stock exchanges about the earnings call. The notification was signed by Suma Upparatti, Company Secretary & Compliance Officer, on January 23, 2026. The earnings call information will also be made available on the company's official website at www.jupiterhospital.com .

Coordination Support

Strategic Growth Advisors Pvt. Ltd. is coordinating the earnings call, with Mandar Chavan and Rahul Agarwal serving as the primary contacts. Participants can reach them at mandar.chavan@sgapl.net or rahul.agarwal@sgapl.net , or through phone numbers 9699382195 and 9821438864 respectively.